We wish to inform that the representatives of the Company will be meeting representatives of Molecule Ventures LLP. The Investor Presentation for Q4 FY26 and previous quarters is already ....
SASKEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sasken Technologies has disclosed a scheduled virtual meeting with representatives of Molecule Ventures LLP on 21st May 2026 from 4 pm to 5 pm. This is a routine regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The meeting will be conducted virtually and any information shared will be based on the Q4 FY26 Investor Presentation already available on the company's website. This is a standard transparency requirement to inform exchanges about company interactions with institutional investors or analysts.
This is a routine disclosure with no immediate impact on the stock. It reflects normal investor relations activity where the company engages with institutional investors while using only publicly available information.